This report contains market size and forecasts of Pharmacogenomics Technology (Theranostics & CDx) in Global, including the following market information:
Global Pharmacogenomics Technology (Theranostics & CDx) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmacogenomics Technology (Theranostics & CDx) market was valued at 9869.6 million in 2021 and is projected to reach US$ 24800 million by 2028, at a CAGR of 14.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Instrument Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmacogenomics Technology (Theranostics & CDx) include Illumina, Roche, Agilent, Abbott, Thermofisher, Qiagen, Guardant Health, MGI Tech Co., Ltd. and Amoydx Biology and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmacogenomics Technology (Theranostics & CDx) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmacogenomics Technology (Theranostics & CDx) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmacogenomics Technology (Theranostics & CDx) Market Segment Percentages, by Type, 2021 (%)
Instrument
Reagents and Consumables
Others
Global Pharmacogenomics Technology (Theranostics & CDx) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmacogenomics Technology (Theranostics & CDx) Market Segment Percentages, by Application, 2021 (%)
Tumor
Diabetes
Mental Diseases
Cardiovascular Diseases
Others
Global Pharmacogenomics Technology (Theranostics & CDx) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmacogenomics Technology (Theranostics & CDx) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmacogenomics Technology (Theranostics & CDx) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmacogenomics Technology (Theranostics & CDx) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Roche
Agilent
Abbott
Thermofisher
Qiagen
Guardant Health
MGI Tech Co., Ltd.
Amoydx Biology
Genomics

LEAVE A REPLY

Please enter your comment!
Please enter your name here